MR analysis indicated that genetically predicted one-unit increase in the log-transformed circulating CRP levels were not associated with prostate cancer risk [odd ratio (OR) 1.06, 95% CI 0.96 to 1.16, and P = 0.24] using the IVW method based on a random-effects model (Figure 2). This evidence concerns the gene CRP and prostate cancer.